- Company Overview for ATEN THERAPEUTICS LTD (SC547221)
- Filing history for ATEN THERAPEUTICS LTD (SC547221)
- People for ATEN THERAPEUTICS LTD (SC547221)
- More for ATEN THERAPEUTICS LTD (SC547221)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
28 Nov 2024 | CS01 | Confirmation statement made on 16 October 2024 with no updates | |
25 Jun 2024 | AA | Total exemption full accounts made up to 30 September 2023 | |
18 Oct 2023 | CS01 | Confirmation statement made on 16 October 2023 with no updates | |
30 Jun 2023 | AA | Accounts for a small company made up to 30 September 2022 | |
17 Oct 2022 | CS01 | Confirmation statement made on 16 October 2022 with no updates | |
03 Aug 2022 | AA01 | Current accounting period shortened from 31 October 2022 to 30 September 2022 | |
27 Jul 2022 | AA | Accounts for a dormant company made up to 31 October 2021 | |
15 Feb 2022 | AP01 | Appointment of Mr Ian Abercrombie as a director on 2 February 2022 | |
26 Oct 2021 | CS01 | Confirmation statement made on 16 October 2021 with updates | |
27 Jul 2021 | AA | Accounts for a dormant company made up to 31 October 2020 | |
16 Oct 2020 | CS01 | Confirmation statement made on 16 October 2020 with no updates | |
16 Oct 2020 | PSC05 | Change of details for Oncobiopharm Limited as a person with significant control on 20 April 2020 | |
13 May 2020 | AA | Accounts for a dormant company made up to 31 October 2019 | |
24 Apr 2020 | AD01 | Registered office address changed from 1 1 Lochrin Square 92-98 Fountainbridge Edinburgh EH3 9QA Scotland to 1 Lochrin Square 92-98 Fountainbridge Edinburgh EH3 9QA on 24 April 2020 | |
24 Apr 2020 | AD01 | Registered office address changed from Whinnyhall House Kinglassie Glenrothes Fife KY5 0UB Scotland to 1 1 Lochrin Square 92-98 Fountainbridge Edinburgh EH3 9QA on 24 April 2020 | |
04 Nov 2019 | CS01 | Confirmation statement made on 21 October 2019 with no updates | |
04 Nov 2019 | PSC02 | Notification of Oncobiopharm Limited as a person with significant control on 1 October 2019 | |
04 Nov 2019 | PSC07 | Cessation of Martin Alexander Quinn as a person with significant control on 1 October 2019 | |
04 Nov 2019 | TM01 | Termination of appointment of Martin Alexander Quinn as a director on 1 October 2019 | |
04 Nov 2019 | AP01 | Appointment of Mr Wilfred Sydney Hanna as a director on 1 October 2019 | |
18 Jul 2019 | AA | Accounts for a dormant company made up to 31 October 2018 | |
21 Oct 2018 | CS01 | Confirmation statement made on 21 October 2018 with no updates | |
11 Oct 2018 | CS01 | Confirmation statement made on 6 October 2018 with no updates | |
06 Jun 2018 | AA | Accounts for a dormant company made up to 31 October 2017 | |
31 Oct 2017 | CS01 | Confirmation statement made on 6 October 2017 with no updates |